Chromadex, Kappa Partner on Vitamin K2 Quality Control

December 3, 2010

ChromaDex Corp. (Irvine, CA) has agreed to supply quality-control methods for Kappa Bioscience’s (Oslo, Norway) vitamin K2 menaquinone-7 ingredients, in both raw-material and finished-goods formats.

ChromaDex Corp. (Irvine, CA) has agreed to supply quality-control methods for Kappa Bioscience’s (Oslo, Norway) vitamin K2 menaquinone-7 ingredients, in both raw-material and finished-goods formats.

ChromaDex will provide analytical reference standards, quality-control methods, and related analytical testing services for Kappa’s vitamin K2 MK-7.

“With increasing market demand for vitamin K2 MK-7, there will be an increase in demand for reference standards, quality-control methods, research tools, and analytical services,” said Frank Jaksch, ChromaDex CEO and cofounder.

“Since MK-7 is a vitamin product manufactured from different sources, it is critical that testing procedures are in place to ensure the quality and consistency of any MK-7-related ingredient or product,” he added.